| Typ : |
Časopis |
| internetový odkaz : |
https://doi.org/10.1007/s40268-023-00433-7 |
|
| výskumné tímy : |
Incheon - Quality Evaluation Team, Samsung Bioepis Co |
| Autori : |
Tak M, Jeong H, Yun J, Kim J, Kim S, Lee Y, Park S-J. |
| titul : |
In‑Use Stability of SB12 (Eculizumab, Soliris Biosimilar) Diluted in Saline and Dextrose Infusion Solution after an Extended Storage Period. |
| Référence : |
Drugs R D ;23,4:363 - 375 2023 |
|
| Úroveň dôkazu : |
|
| fyzikálna stabilita : |
|
| chemická stabilita : |
|
| iné metódy : |
|
| Komentáre : |
| Proteíny: biologická aktivita enzýmovou technikou |
|
Zoznam zlúčenín
 Eculizumab
|
 |
 |
 |
 |
 |
 |
 |
 |
 |
5 mg/ml |
2-8°C |
 |
| 90 |
 |
|
 |
|
|
|
5 mg/ml |
28-32°C |
|
| 72 |
 |
|
|
|
|
 |
5 mg/ml |
2-8°C |
|
| 90 |
|
|
|
|
|
|
5 mg/ml |
28-32°C |
|
| 72 |
|
|
|
|
 |
|
5 mg/ml |
2-8°C |
|
| 90 |
|
|
|
|
|
|
5 mg/ml |
28-32°C |
|
| 72 |
|
|
|
|
|
|
5 mg/ml |
2-8°C |
|
| 90 |
|
|
|
|
|
|
5 mg/ml |
28-32°C |
|
| 72 |
|
|
|
|
|
